173 related articles for article (PubMed ID: 17326939)
41. Relationship between occurrence of Guillain-Barre syndrome and mass campaign of measles and rubella immunization in Iranian 5-14 years old children.
Esteghamati A; Gouya MM; Keshtkar AA; Mahoney F
Vaccine; 2008 Sep; 26(39):5058-61. PubMed ID: 18662736
[TBL] [Abstract][Full Text] [Related]
42. [A case-control study on Guillain-Barre syndrome in children of North China].
Wu Z; Wu H; Wang Q; Zhaori G; Wang C; Liang Z; Shan G; Cui S; Pan L; Zheng J; Zuo Q; Zhang Y; Zhang K
Zhonghua Yu Fang Yi Xue Za Zhi; 1999 Sep; 33(5):279-81. PubMed ID: 11864491
[TBL] [Abstract][Full Text] [Related]
43. Validation of an ELISA for the diagnosis of recent Campylobacter infections in Guillain-Barré and reactive arthritis patients.
Ang CW; Krogfelt K; Herbrink P; Keijser J; van Pelt W; Dalby T; Kuijf M; Jacobs BC; Bergman MP; Schiellerup P; Visser CE
Clin Microbiol Infect; 2007 Sep; 13(9):915-22. PubMed ID: 17608745
[TBL] [Abstract][Full Text] [Related]
44. Campylobacter coli enteritis and Guillain-Barré syndrome: no evidence of molecular mimicry and serological relationship.
Funakoshi K; Koga M; Takahashi M; Hirata K; Yuki N
J Neurol Sci; 2006 Jul; 246(1-2):163-8. PubMed ID: 16600306
[TBL] [Abstract][Full Text] [Related]
45. Intrathecal antibody responses to GalC in Guillain-Barré syndrome triggered by Mycoplasma pneumoniae.
Meyer Sauteur PM; Huizinga R; Tio-Gillen AP; Drenthen J; Unger WWJ; Jacobs E; van Rossum AMC; Jacobs BC
J Neuroimmunol; 2018 Jan; 314():13-16. PubMed ID: 29301655
[TBL] [Abstract][Full Text] [Related]
46. A 3-year-old boy with Guillain-Barré syndrome and encephalitis associated with Mycoplasma pneumoniae infection.
Hanzawa F; Fuchigami T; Ishii W; Nakajima S; Kawamura Y; Endo A; Arakawa C; Kohira R; Fujita Y; Takahashi S
J Infect Chemother; 2014 Feb; 20(2):134-8. PubMed ID: 24462436
[TBL] [Abstract][Full Text] [Related]
47. Large Outbreak of Guillain-Barré Syndrome, Peru, 2019.
Munayco CV; Gavilan RG; Ramirez G; Loayza M; Miraval ML; Whitehouse E; Gharpure R; Soares J; Soplopuco HV; Sejvar J
Emerg Infect Dis; 2020 Nov; 26(11):2778-2780. PubMed ID: 33079047
[TBL] [Abstract][Full Text] [Related]
48. Relationship between pathogenesis of Guillain-Barre syndrome and Penner's serotypes of Campylobacter jejuni.
Li H; Yuan J; Shen B; Sun X; Hao H
Chin Med J (Engl); 1999 Sep; 112(9):794-6. PubMed ID: 11717947
[TBL] [Abstract][Full Text] [Related]
49. The risk of Guillain-Barré syndrome associated with influenza A (H1N1) 2009 monovalent vaccine and 2009-2010 seasonal influenza vaccines: results from self-controlled analyses.
Tokars JI; Lewis P; DeStefano F; Wise M; Viray M; Morgan O; Gargiullo P; Vellozzi C
Pharmacoepidemiol Drug Saf; 2012 May; 21(5):546-52. PubMed ID: 22407672
[TBL] [Abstract][Full Text] [Related]
50. [Guillain-Barré syndrome secondary to Mycoplasma pneumoniae infection].
Villanueva JE; Marteles MS; Allué RM
Neurologia; 2007 Oct; 22(8):556. PubMed ID: 18000765
[No Abstract] [Full Text] [Related]
51. Lack of association of Guillain-Barré syndrome with vaccinations.
Baxter R; Bakshi N; Fireman B; Lewis E; Ray P; Vellozzi C; Klein NP
Clin Infect Dis; 2013 Jul; 57(2):197-204. PubMed ID: 23580737
[TBL] [Abstract][Full Text] [Related]
52. Bilateral optic neuritis and Guillain-Barré syndrome following an acute Mycoplasma pneumoniae infection.
Ginestal RC; Plaza JF; Callejo JM; Rodríguez-Espinosa N; Fernández-Ruiz LC; Masjuán J
J Neurol; 2004 Jun; 251(6):767-8. PubMed ID: 15311361
[No Abstract] [Full Text] [Related]
53. Antecedent infections in Guillain-Barré syndrome: a single-center, prospective study.
Hao Y; Wang W; Jacobs BC; Qiao B; Chen M; Liu D; Feng X; Wang Y
Ann Clin Transl Neurol; 2019 Dec; 6(12):2510-2517. PubMed ID: 31714025
[TBL] [Abstract][Full Text] [Related]
54. Immunoadsorption therapy for a child with Guillain-Barre syndrome subsequent to Mycoplasma infection: a case study.
Arakawa H; Yuhara Y; Todokoro M; Kato M; Mochizuki H; Tokuyama K; Kunimoto F; Morikawa A
Brain Dev; 2005 Sep; 27(6):431-3. PubMed ID: 16122631
[TBL] [Abstract][Full Text] [Related]
55. Prospective study on anti-ganglioside antibodies in childhood Guillain-Barré syndrome.
Schessl J; Koga M; Funakoshi K; Kirschner J; Muellges W; Weishaupt A; Gold R; Korinthenberg R
Arch Dis Child; 2007 Jan; 92(1):48-52. PubMed ID: 16920757
[TBL] [Abstract][Full Text] [Related]
56. Incidence of Guillain-Barré syndrome among patients with Campylobacter infection: a general practice research database study.
Tam CC; Rodrigues LC; Petersen I; Islam A; Hayward A; O'Brien SJ
J Infect Dis; 2006 Jul; 194(1):95-7. PubMed ID: 16741887
[TBL] [Abstract][Full Text] [Related]
57. A case of Guillain-Barrè syndrome following Staphylococcus aureus endocarditis.
Baravelli M; Rossi A; Picozzi A; Gavazzi A; Imperiale D; Dario P; Fantoni C; Borghi S; Anza' C
Int J Cardiol; 2007 Jan; 114(2):E53-5. PubMed ID: 17070944
[TBL] [Abstract][Full Text] [Related]
58. Incidence of
Scallan Walter EJ; Crim SM; Bruce BB; Griffin PM
Foodborne Pathog Dis; 2020 Jan; 17(1):23-28. PubMed ID: 31509036
[TBL] [Abstract][Full Text] [Related]
59. Seroprevalence of campylobacteriosis and relevant post-infectious sequelae.
Zautner AE; Johann C; Strubel A; Busse C; Tareen AM; Masanta WO; Lugert R; Schmidt-Ott R; Groß U
Eur J Clin Microbiol Infect Dis; 2014 Jun; 33(6):1019-27. PubMed ID: 24413899
[TBL] [Abstract][Full Text] [Related]
60. Near real-time surveillance for Guillain-Barré syndrome after influenza vaccination among the Medicare population, 2010/11 to 2013/14.
Sandhu SK; Hua W; MaCurdy TE; Franks RL; Avagyan A; Kelman J; Worrall CM; Ball R; Nguyen M
Vaccine; 2017 May; 35(22):2986-2992. PubMed ID: 28449973
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
